Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

RARE DISEASE COMPANY COALITION

Filed by RARE DISEASE COMPANY COALITION.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 16, 2025
Income
Not reported
Expenses
$90,000.00
Filing UUID
67888327-ceb1-4fd9-b580-50cd3b9b51e1
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

HR 1 - Big Beautiful Bill Act

Literal federal measure citations: HR 1

PHA · Pharmacy

HR 1262 - Give Kids a Chance Act of 2025 S 932 - Give Kids a Chance Act of 2025 HR 946 - ORPHAN Cures Act S 1862 - ORPHAN Cures Act HR 1414 - Camerons Law Drug Pricing EO 14297: Most Favored Nation Pricing Proposals

Literal federal measure citations: HR 1262, S 932, HR 946, S 1862, HR 1414

TRD · Trade (domestic/foreign)

Sec. 232 Pharmaceutical Tariffs

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.